Onzeald

RSS

etirinotecan pegol

Refused
This medicine was refused authorisation for use in the European Union.

Overview

This EPAR was last updated on 02/02/2018

Application details

Product details
Name
Onzeald
Active substance
etirinotecan pegol
International non-proprietary name (INN) or common name
etirinotecan pegol
Therapeutic area (MeSH)
Breast Neoplasms
Anatomical therapeutic chemical (ATC) code
L01
Application details
Marketing-autorisation applicant
Nektar Therapeutics UK Limited
Date of opinion
09/11/2017
Date of refusal of marketing authorisation
08/01/2018

Assessment history

How useful was this page?

Add your rating